You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动 | 普华和顺涨逾12% 拟参与私有化血液制品公司
格隆汇 09-19 10:14
格隆汇9月19日丨普华和顺(1358.HK)现逆势涨12.24%,报1.1港元,暂成交387万港元,最新总市值17.3亿。公司公告称,拟作价1.01亿美元向Centurium出售100万股CBPO股份,完成后公司于CBPO之持股比例将减少至13.91%。此外,公司已与其他初步财团成员订立财团协议。根据私有化建议,财团成员拟收购财团尚未拥有之所有已发行CBPO股份。私有化建议完成后,由财团组成的收购控股公司预期将直接或间接持有CBPO的100%股权。而公司拟作出532.1万股CBPO股份的出资参与设立收购控股公司。据悉,CBPO在纳斯达克股票交易所上市,为一间于中国主要从事研发、生产及销售血液生物制品或血液制品的生物制药公司。公司将出售事项所得款项拟用于偿还公司的债务融资、固定资产支出、营运资金及其他一般企业用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account